Related Experiment Video
Updated: Apr 24, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Molecular docking and P-glycoprotein inhibitory activity of flavonoids
Jayasimha Rayalu Daddam1, Muralidhara Rao Dowlathabad, Seshapani Panthangi
1Department of Biotechnology, Global Institute of Biotechnology, Himayatnagar, Hyderabad-29, Andhra Pradesh, India.
Abstract:
Flavonoids are the most common group of phenolic compounds that have anti-carcinogenic properties and are the constituents of fruits, vegetables and plant derived beverages. In the present study, Flavonoids were docked to three-dimensional structure of P-glycoprotein which plays an important role in multi drug resistance. A three-dimensional homology model of human P-glycoprotein was built, based on the crystal structure of the 3G5U (Chain A; Structure of a bacterial multidrug ABC transporter) by using Modeller7v7 software. Homology modelling provided a good quality model of the corresponding region in human P-glycoprotein. With the aid of the molecular mechanics and molecular dynamics methods, the final model is obtained and is further assessed by PROCHECK and verify 3D graph programs, which showed that the final refined model is reliable. With this model, a flexible docking study of P-glycoprotein with a group of Flavonoids which were selected from the previous publications was performed. The results indicated THR37, ALA42, ARG40 and ARG47 in P-glycoprotein are important determinant residues in binding as they have strong hydrogen bonding with Flavonoids. These hydrogen binding interactions play an important role for stability of the complex. Among the 10 Flavonoids docked, BiochaninA showed best docking result with P-glycoprotein. Our results may be helpful for further experimental investigations.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacokinetics: Drug–Drug Interactions
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...